Exelixis gets FDA label expansion for Cabometyx in neuroendocrine tumors
Exelixis (EXEL) wins FDA approval for Cabometyx for advanced pancreatic and extra pancreatic neuroendocrine tumors in ...
Benitec Biopharma prices $30M securities offerings
Benitec Biopharma (BNTC) aims to raise $30M through stock and pre-funded warrant offerings. Proceeds to fund product development and corporate growth.
Clearmind Medicine’s FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key Milestones
CMND-100, a proprietary MEAI-based oral drug candidate, represents a potential breakthrough in AUD treatment, targeting the reduction of alcohol consumption and cravings through a novel mechanism of ...